BioHarvest Sciences Inc.
Other OTCTotal Valuation
BioHarvest Sciences Inc. carries a market capitalization of 109.16M, placing it among publicly traded companies globally. Its enterprise value stands at 92.65M, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.
| Market Cap | 109.16M |
| Enterprise Value | 92.65M |
Share Statistics
BioHarvest Sciences Inc. currently has 17.33M shares outstanding.
| Shares Outstanding | 17.33M |
| Owned by Insiders (%) | N/A |
| Owned by Institutions (%) | N/A |
Valuation Ratios
The price-to-sales ratio is 3.78, and the price-to-book ratio stands at 20.47.
| PE Ratio | N/A |
| PS Ratio | 3.78 |
| PB Ratio | 20.47 |
| P/TBV Ratio | 20.47 |
| P/FCF Ratio | -18.59 |
| P/OCF Ratio | -11.62 |
Enterprise Valuation
| EV / Sales | 4.13 |
| EV / EBITDA | N/A |
| EV / EBIT | N/A |
| EV / FCF | 30.18 |
Financial Position
BioHarvest Sciences Inc. maintains a current ratio of 0.80, meaning it holds 0.8x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 258.44, indicating elevated leverage, while an interest coverage ratio of -0.88 demonstrates limited ability to service its debt obligations.
| Current Ratio | 0.80 |
| Quick Ratio | 0.48 |
| Debt / Equity | 258.44 |
| Debt / EBITDA | -1.59 |
| Interest Coverage | -0.88 |
Financial Efficiency
| Return on Equity (ROE) | N/A |
| Return on Assets (ROA) | -94.42 |
| Return on Invested Capital (ROIC) | N/A |
| Return on Capital Employed (ROCE) | N/A |
| Revenue Per Employee | N/A |
| Employee Count | N/A |
| Inventory Turnover | 3.92 |
Stock Price Statistics
BioHarvest Sciences Inc.'s stock has gained approximately 12.70125% over the past 52 weeks. The 50-day moving average sits at - -, while the 200-day moving average is - -.
| Beta (5Y) | N/A |
| 52-Week Price Change | 12.70125% |
| 50-Day Moving Average | - - |
| 200-Day Moving Average | - - |
| Average Volume (20 Days) | N/A |
Income Statement
Over the trailing twelve months, BioHarvest Sciences Inc. generated 22.43M in revenue and converted that into -17.19M in net income, yielding earnings per share of -1.14. EBITDA reached -6.72M, while operating income came in at -7.85M.
| Revenue | 22.43M |
| Gross Profit | 12.11M |
| Operating Income | -7.85M |
| Pretax Income | -17.19M |
| Net Income | -17.19M |
| EBITDA | -6.72M |
| EBIT | -7.85M |
| Earnings Per Share (EPS) | -1.14 |
Balance Sheet
BioHarvest Sciences Inc. holds 2.77M in cash and equivalents against 10.70M in total debt, resulting in a net debt position of -1.57M. Total book value stands at 4.14M, with working capital of -1.95M providing operational flexibility.
| Cash & Cash Equivalents | 2.77M |
| Total Debt | 10.70M |
| Net Debt | -1.57M |
| Equity (Book Value) | 4.14M |
| Book Value Per Share | 0.28 |
| Working Capital | -1.95M |
Cash Flow
BioHarvest Sciences Inc. produced -7.29M in operating cash flow over the past twelve months. After subtracting -2.73M in capital expenditures, free cash flow totaled -10.02M - equivalent to -0.67 per share.
| Operating Cash Flow | -7.29M |
| Capital Expenditures | -2.73M |
| Free Cash Flow | -10.02M |
| FCF Per Share | -0.67 |
Margins
BioHarvest Sciences Inc. operates with a gross margin of 54.00, reflecting its pricing power and cost economics. The operating margin of -35.00 and net profit margin of -76.65 provide insight into operational efficiency.
| Gross Margin | 54.00 |
| Operating Margin | -35.00 |
| Pretax Margin | -76.65 |
| Profit Margin | -76.65 |
| EBITDA Margin | -29.98 |
Dividends & Yields
| Dividend Per Share | N/A |
| Dividend Yield | N/A |
| Payout Ratio | N/A |
| Shareholder Yield | -13.38 |
| FCF Yield | -5.38 |
Stock Splits
BioHarvest Sciences Inc.'s most recent stock split took place on June 3, 2024 with a 35:1 split ratio.
| Last Split Date | 6/3/2024 |
| Split Ratio | 35:1 |
Scores
BioHarvest Sciences Inc. posts an Altman Z-Score of -2.95, below the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.
| Altman Z-Score | -2.95 |